BioCentury
ARTICLE | Company News

Medicines Co., Quintiles sales and marketing update

December 11, 2000 8:00 AM UTC

QTRN's Innovex Inc. business unit (Parsippany, N.J.) will provide a sales force and promote MDCO's Angiomax bivalirudin direct thrombin inhibitor following final FDA approval of the compound to treat...